Signet Financial Management LLC Sells 3,595 Shares of Fresenius Medical Care AG (NYSE:FMS)

Signet Financial Management LLC decreased its holdings in Fresenius Medical Care AG (NYSE:FMS) by 10.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,617 shares of the company’s stock after selling 3,595 shares during the period. Signet Financial Management LLC’s holdings in Fresenius Medical Care were worth $716,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Allworth Financial LP boosted its stake in Fresenius Medical Care by 53.1% in the 3rd quarter. Allworth Financial LP now owns 1,675 shares of the company’s stock worth $36,000 after purchasing an additional 581 shares during the period. Wilmington Savings Fund Society FSB purchased a new position in shares of Fresenius Medical Care in the third quarter worth $38,000. GAMMA Investing LLC boosted its position in shares of Fresenius Medical Care by 50.4% during the third quarter. GAMMA Investing LLC now owns 4,998 shares of the company’s stock worth $106,000 after acquiring an additional 1,675 shares during the last quarter. ORG Wealth Partners LLC purchased a new position in Fresenius Medical Care during the third quarter valued at $112,000. Finally, Venturi Wealth Management LLC increased its holdings in Fresenius Medical Care by 1,045.8% in the 3rd quarter. Venturi Wealth Management LLC now owns 5,259 shares of the company’s stock valued at $112,000 after acquiring an additional 4,800 shares during the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on the company. StockNews.com started coverage on Fresenius Medical Care in a report on Friday, January 3rd. They set a “strong-buy” rating on the stock. Truist Financial upped their price target on shares of Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Berenberg Bank assumed coverage on shares of Fresenius Medical Care in a research report on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. Finally, Bank of America upgraded Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd.

Fresenius Medical Care Stock Down 0.7 %

Shares of FMS traded down $0.15 during trading hours on Monday, hitting $22.34. The company had a trading volume of 293,111 shares, compared to its average volume of 211,316. Fresenius Medical Care AG has a one year low of $17.93 and a one year high of $24.31. The company has a market capitalization of $13.11 billion, a PE ratio of 18.46, a price-to-earnings-growth ratio of 0.95 and a beta of 0.92. The company has a current ratio of 1.37, a quick ratio of 1.02 and a debt-to-equity ratio of 0.42. The company’s fifty day moving average price is $22.50 and its two-hundred day moving average price is $20.78.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.